Correlation Between Defence Therapeutics and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Defence Therapeutics and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Defence Therapeutics and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Eledon Pharmaceuticals.

Diversification Opportunities for Defence Therapeutics and Eledon Pharmaceuticals

-0.31

Correlation Coefficient

Defence Therapeutics  Eledon Pharmaceuticals

Very good diversification

The 3 months correlation between Defence and Eledon is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Defence Therapeutics and Eledon Pharmaceuticals

Assuming the 90 days horizon Defence Therapeutics is expected to generate 2.53 times more return on investment than Eledon Pharmaceuticals. However, Defence Therapeutics is 2.53 times more volatile than Eledon Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  39.00  in Defence Therapeutics on December 29, 2024 and sell it today you would earn a total of  61.00  from holding Defence Therapeutics or generate 156.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.83%
Values	Daily Returns

Defence Therapeutics  vs.  Eledon Pharmaceuticals

Defence Therapeutics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Defence Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eledon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Defence Therapeutics and Eledon Pharmaceuticals

The main advantage of trading using opposite Defence Therapeutics and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Defence Therapeutics and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.